Thailand - Women's share of population ages 15+ living with HIV (%)

Women's share of population ages 15+ living with HIV (%) in Thailand was 43.40 as of 2020. Its highest value over the past 30 years was 45.90 in 2011, while its lowest value was 12.60 in 1990.

Definition: Prevalence of HIV is the percentage of people who are infected with HIV. Female rate is as a percentage of the total population ages 15+ who are living with HIV.

Source: UNAIDS estimates.

See also:

Year Value
1990 12.60
1991 15.90
1992 19.00
1993 21.90
1994 24.70
1995 27.30
1996 29.70
1997 32.00
1998 34.10
1999 35.90
2000 37.60
2001 39.10
2002 40.40
2003 41.60
2004 42.70
2005 43.60
2006 44.30
2007 44.90
2008 45.40
2009 45.70
2010 45.80
2011 45.90
2012 45.80
2013 45.70
2014 45.50
2015 45.20
2016 44.90
2017 44.60
2018 44.20
2019 43.80
2020 43.40

Limitations and Exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information.

Statistical Concept and Methodology: HIV prevalence rates reflect the rate of HIV infection in each country's population. Low national prevalence rates can be misleading, however. They often disguise epidemics that are initially concentrated in certain localities or population groups and threaten to spill over into the wider population. In many developing countries most new infections occur in young adults, with young women especially vulnerable. Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. The models, which are routinely updated, track the course of HIV epidemics and their impact, making full use of information in HIV prevalence trends from surveillance data as well as survey data. The models take into account reduced infectivity among people receiving antiretroviral therapy (which is having a larger impact on HIV prevalence and allowing HIV-positive people to live longer) and allow for changes in urbanization over time in generalized epidemics. The estimates include plausibility bounds, which reflect the certainty associated with each of the estimates.

Aggregation method: Weighted average

Periodicity: Annual

Classification

Topic: Health Indicators

Sub-Topic: Risk factors